Leadership changes in companies, especially in the biotech sector, can significantly influence investor sentiment and stock prices. The appointment of a new CEO often brings optimism about potential strategic shifts and growth, which could positively impact Aileron Therapeutics' stock in the short term. However, the actual impact will depend on the market's perception of Brian Windsor's leadership capabilities and the strategic direction he sets for the company.